Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | KEGG DRUG | DrugBank | Drug (Description in trials) | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 |
Blinatumomab
💬 (Blinatumomab (USAN/INN), Blinatumomab (genetical recombination) (JAN)) | [1] Blinatumomab Blinatumomab (Blinatumomab) | [1] Blinatumomab Blinatumomab | [4] CD19 CD19,CD3D, CD3E, CD3G 💬 | [13] B cell receptor signaling pathway B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [3] 11 11, 46, 49 💬
|